Schedule 13G ownership disclosure

ENDONOVO THERAPEUTICS, INC.

Security class unavailable · CUSIP: 29272H201

Event date: 2017-03-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-017045
Form type
SC 13G
Filer
ENDONOVO THERAPEUTICS, INC.
CIK
CIK 1528172
Filed
Mar 28, 2017
Reporting period
Mar 20, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub